Literature DB >> 17173972

Classical pathway complement activation on human endothelial cells.

Wei Yin1, Berhane Ghebrehiwet, Babette Weksler, Ellinor I Peerschke.   

Abstract

Endothelial cells regulate vascular integrity and express complement binding proteins including gC1qR/p33 (gC1qR), which recognize C1q, a subunit of the first component of the classical complement pathway. Experiments were performed to investigate classical complement pathway activation on resting endothelial cells and endothelial cells exposed to shear stress. C1q deposition and C4 activation (C4d) were demonstrated by solid phase ELISA and flow cytometry on human microvascular and umbilical vein endothelial cells after exposure to serum or plasma. C4d deposition was accompanied by downstream complement activation including C3b and C5b-9 deposition. C4 activation failed to occur in C1q depleted serum, but was not affected by Factor B depleted serum, confirming classical complement pathway activation. Moreover, C4 activation occurred following exposure of endothelial cells to purified C1 and C4, in the absence of other plasma proteins, and in the absence of detectable cell surface IgG and IgM. Shear stress (18 dynes/cm2) increased C1q (n=9, p<0.05) and C4d (n=9, p<0.05) deposition approximately two-fold, and enhanced endothelial cell gC1qR expression (n=7, p<0.05). Treatment of endothelial cells with anti gC1qR monoclonal antibody F(ab')2 fragments reduced C4d deposition by approximately 20% (n=5, p<0.05). These data demonstrate direct classical complement pathway activation on endothelial cells. gC1qR appears to play a minor but definable role, whereas cell surface IgG or IgM are not required.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17173972      PMCID: PMC1865514          DOI: 10.1016/j.molimm.2006.11.012

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  34 in total

1.  Up-regulation of endothelial cell binding proteins/receptors for complement component C1q by inflammatory cytokines.

Authors:  W X Guo; B Ghebrehiwet; B Weksler; K Schweitzer; E I Peerschke
Journal:  J Lab Clin Med       Date:  1999-06

Review 2.  The role of c5b-9 terminal complement complex in activation of the cell cycle and transcription.

Authors:  Matthew Fosbrink; Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects.

Authors:  Sridevi Devaraj; Terry W Du Clos; Ishwarlal Jialal
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-04-28       Impact factor: 8.311

4.  Differential effects of orbital and laminar shear stress on endothelial cells.

Authors:  Alan Dardik; Leiling Chen; Jared Frattini; Hidenori Asada; Faisal Aziz; Fabio A Kudo; Bauer E Sumpio
Journal:  J Vasc Surg       Date:  2005-05       Impact factor: 4.268

Review 5.  Inflammation and coronary artery disease.

Authors:  Alice Y Tiong; David Brieger
Journal:  Am Heart J       Date:  2005-07       Impact factor: 4.749

6.  C3a and C5a enhance granulocyte adhesion to endothelial and epithelial cell monolayers: epithelial and endothelial priming is required for C3a-induced eosinophil adhesion.

Authors:  M A Jagels; P J Daffern; T E Hugli
Journal:  Immunopharmacology       Date:  2000-03

7.  Complement activation and atherosclerosis.

Authors:  F Niculescu; H Rus
Journal:  Mol Immunol       Date:  1999 Sep-Oct       Impact factor: 4.407

8.  Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis.

Authors:  Walter S Speidl; Markus Exner; Jasmin Amighi; Stefan P Kastl; Gerlinde Zorn; Gerald Maurer; Oswald Wagner; Kurt Huber; Erich Minar; Johann Wojta; Martin Schillinger
Journal:  Eur Heart J       Date:  2005-05-25       Impact factor: 29.983

9.  Complement and atherogenesis: the unknown connection.

Authors:  S Bhakdi
Journal:  Ann Med       Date:  1998-12       Impact factor: 4.709

10.  Blood-brain barrier-specific properties of a human adult brain endothelial cell line.

Authors:  B B Weksler; E A Subileau; N Perrière; P Charneau; K Holloway; M Leveque; H Tricoire-Leignel; A Nicotra; S Bourdoulous; P Turowski; D K Male; F Roux; J Greenwood; I A Romero; P O Couraud
Journal:  FASEB J       Date:  2005-09-01       Impact factor: 5.191

View more
  11 in total

1.  Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium.

Authors:  Roberta Bulla; Chiara Agostinis; Fleur Bossi; Lucia Rizzi; Alessandra Debeus; Claudio Tripodo; Oriano Radillo; Francesco De Seta; Berhane Ghebrehiwet; Francesco Tedesco
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

2.  Soluble gC1qR is an autocrine signal that induces B1R expression on endothelial cells.

Authors:  Berhane Ghebrehiwet; Yan Ji; Alisa Valentino; Lina Pednekar; Mahalakshmi Ramadass; David Habiel; Richard R Kew; Kinga H Hosszu; Dennis K Galanakis; Uday Kishore; Ellinor I B Peerschke
Journal:  J Immunol       Date:  2013-12-06       Impact factor: 5.422

3.  gC1qR Antibody Can Modulate Endothelial Cell Permeability in Angioedema.

Authors:  Marina Fandaros; Kusumam Joseph; Allen P Kaplan; David A Rubenstein; Berhane Ghebrehiwet; Wei Yin
Journal:  Inflammation       Date:  2021-09-07       Impact factor: 4.092

4.  Regulated complement deposition on the surface of human endothelial cells: effect of tobacco smoke and shear stress.

Authors:  Wei Yin; Berhane Ghebrehiwet; Babette Weksler; Ellinor I B Peerschke
Journal:  Thromb Res       Date:  2007-12-31       Impact factor: 3.944

Review 5.  Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis.

Authors:  Franca Orsini; Daiana De Blasio; Rosalia Zangari; Elisa R Zanier; Maria-Grazia De Simoni
Journal:  Front Cell Neurosci       Date:  2014-11-07       Impact factor: 5.505

6.  Analysis of the Interaction between Globular Head Modules of Human C1q and Its Candidate Receptor gC1qR.

Authors:  Lina Pednekar; Ansar A Pathan; Basudev Paudyal; Anthony G Tsolaki; Anuvinder Kaur; Suhair M Abozaid; Lubna Kouser; Haseeb A Khan; Ellinor I Peerschke; Mohamed H Shamji; Gudrun Stenbeck; Berhane Ghebrehiwet; Uday Kishore
Journal:  Front Immunol       Date:  2016-12-13       Impact factor: 7.561

7.  Serum Level of Complement C1q is Associated with Contrast-Associated Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention.

Authors:  Jun Tao; Chenglin Ye; Wen Dai; Di Li; Man Zhou; Yan Li
Journal:  J Inflamm Res       Date:  2021-12-24

Review 8.  Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation.

Authors:  Zivile Bekassy; Ingrid Lopatko Fagerström; Michael Bader; Diana Karpman
Journal:  Nat Rev Immunol       Date:  2021-11-10       Impact factor: 108.555

9.  Complement activation in astrocytomas: deposition of C4d and patient outcome.

Authors:  Katri Mäkelä; Pauli Helén; Hannu Haapasalo; Timo Paavonen
Journal:  BMC Cancer       Date:  2012-12-01       Impact factor: 4.430

10.  The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets.

Authors:  Henry Nording; Lasse Baron; David Haberthür; Frederic Emschermann; Matthias Mezger; Manuela Sauter; Reinhard Sauter; Johannes Patzelt; Kai Knoepp; Anne Nording; Moritz Meusel; Roza Meyer-Saraei; Ruslan Hlushchuk; Daniel Sedding; Oliver Borst; Ingo Eitel; Christian M Karsten; Robert Feil; Bernd Pichler; Jeanette Erdmann; Admar Verschoor; Emmanouil Chavakis; Triantafyllos Chavakis; Philipp von Hundelshausen; Jörg Köhl; Meinrad Gawaz; Harald F Langer
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.